Home Cart Sign in  
Chemical Structure| 89391-50-4 Chemical Structure| 89391-50-4

Structure of Imirestat
CAS No.: 89391-50-4

Chemical Structure| 89391-50-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Imirestat (AL 1576) is an aldose reductase inhibitor used in diabetes research.

Synonyms: AL 1576; Alcon 1576; AL-01576

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Imirestat

CAS No. :89391-50-4
Formula : C15H8F2N2O2
M.W : 286.23
SMILES Code : O=C1NC2(C(N1)=O)C3=C(C4=C2C=C(F)C=C4)C=CC(F)=C3
Synonyms :
AL 1576; Alcon 1576; AL-01576
MDL No. :MFCD00865639

Safety of Imirestat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat retinal endothelial cells (TR-iBRB) 10 μM 48 hours To investigate the effects of high glucose or galactose media on growth factors and signaling pathways in endothelial cells. Results showed no changes in growth factors or signaling pathways in endothelial cells cultured in high glucose media, while increased expression of growth factors (bFGF, IGF-1, TGF-β) and partial signaling pathways (P-ERK1/2, P-SAPK/JNK) was observed in galactose media, and these changes were partially inhibited by ARIs. J Ocul Pharmacol Ther. 2014 Feb;30(1):4-11

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Acute kidney injury model Intraperitoneal injection 20, 40, 80 or 120 mg/kg body weight Single injection followed by 18 hours To evaluate the protective effect of Imirestat against acute kidney injury, results showed that Imirestat failed to provide protection J Med Chem. 2023 Apr 27;66(8):5657-5668

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.49mL

0.70mL

0.35mL

17.47mL

3.49mL

1.75mL

34.94mL

6.99mL

3.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories